By a GenomeWeb staff reporter

NEW YORK (Genomeweb News) – Enzo Biochem today said that a decision by an appellate court last week that reversed a district court's summary judgment enables the firm to pursue a claim for "substantial damages" against Life Technologies.

Enzo said that the Court of Appeals for the Federal Circuit had vacated the lower court's judgment of invalidity for US Patent Nos. 5,328,824 and 5,449,767.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

NPR reports that with medical data being big business, some companies want to get patients involved.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.